September issue highlights:
γ-protocadherins in atherosclerosis; glatiramer acetate repurposing to treat cardiac ischemia, systemic lupus erythematosus antibodies and myocardial injury, and more!
γ-protocadherins in atherosclerosis; glatiramer acetate repurposing to treat cardiac ischemia, systemic lupus erythematosus antibodies and myocardial injury, and more!
The endocardium is activated immediately after injury and promotes cardiac muscle regeneration by producing growth factors. Research now shows that innate immune signaling is crucial for the regenerative function of the endocardium.